EFLM 2023 欧洲尿液分析指南
欧洲临床化学与检验医学联盟(EFLM)尿液分析工作组更新了2000年版欧洲尿液分析指南,针对尿液分析及尿细菌培养提出分级推荐,覆盖医需与申请、标本采集、化学、颗粒计数、细菌学等方面,旨在提高欧洲临床实验室检查准确性并支持诊断技术开发。
要点
- 推荐检测尿白蛋白和α1-微球蛋白以敏感发现高危患者的肾脏疾病。
- 推荐显色琼脂作为尿培养初代培养基,并优化工作流程。
- 建议采用白细胞尿减少不必要的抗菌药物敏感性试验。
核心结论
- EFLM 更新了欧洲尿液分析指南,为尿液分析及尿细菌培养提供分级推荐,以提高检查准确性并支持诊断技术开发。
研究设计与样本
- 由 EFLM 尿液分析工作组对2000年版 ECLM 欧洲尿液分析指南进行更新,制定分级推荐。
主要发现
- 推荐检测尿白蛋白和α1-微球蛋白用于高危患者肾脏疾病的敏感检测。
- 推荐显色琼脂作为尿培养初代培养基,并优化常规标本工作流程,利用白细胞尿减少不太重要的抗菌药物敏感性试验。
- 将 Aerococcus urinae、A. sanguinicola 和 Actinotignum schaalii 纳入尿路病原体列表。
- 制定了尿细菌培养的参考检查程序。
关键数值与推荐
- 尿液分析质量指标包括培养污染率和尿液密度(化学、颗粒)。
- 给出了尿液蛋白测量的性能规格和多项目试纸条测试的质量控制要求。
临床怎么用
- 对高危肾病患者应检测尿白蛋白和α1-微球蛋白以提高肾脏疾病检出敏感性。
- 尿培养推荐使用显色琼脂作为初代培养基,并可采用白细胞尿优化抗菌药物敏感性试验流程。
- 自动化颗粒计数和视觉显微镜检查应参照参考显微镜检查进行验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The EFLM Task and Finish Group Urinalysis has updated the ECLM European Urinalysis Guidelines (2000) on urinalysis and urine bacterial culture, to improve accuracy of these examinations in European clinical laboratories, and to support diagnostic industry to develop new technologies. RECOMMENDATIONS: Graded recommendations were built in the following areas. MEDICAL NEEDS AND TEST REQUISITION: Strategies of urine testing are described to patients with complicated or uncomplicated urinary tract infection (UTI), and high or low-risk to kidney disease. SPECIMEN COLLECTION: Patient preparation, and urine collection are supported with two quality indicators: contamination rate (cultures), and density of urine (chemistry, particles). CHEMISTRY: Measurements of both urine albumin and α1-microglobulin are recommended for sensitive detection of kidney disease in high-risk patients. Performance specifications are given for urine protein measurements and quality control of multiproperty strip tests. PARTICLES: Procedures for microscopy are reviewed for diagnostic urine particles, including urine bacteria. Technologies in automated particle counting and visual microscopy are updated with advice how to verify new instruments with the reference microscopy. BACTERIOLOGY: Chromogenic agar is recommended as primary medium in urine cultures. Limits of significant growth are reviewed, with an optimised workflow for routine specimens, using leukocyturia to reduce less important antimicrobial susceptibility testing. Automation in bacteriology is encouraged to shorten turn-around times. Matrix assisted laser desorption ionization time-of-flight mass spectrometry is applicable for rapid identification of uropathogens. Aerococcus urinae, A. sanguinicola and Actinotignum schaalii are taken into the list of uropathogens. A reference examination procedure was developed for urine bacterial cultures.
引用
- Kouri TT, Hofmann W, Falbo R, et al. The EFLM European Urinalysis Guideline 2023. Clin Chem Lab Med. 2024. PMID: 38534005. doi:10.1515/cclm-2024-0070
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。